These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4102260)

  • 1. Differential effects of 6-mercaptopurine and cyclophosphamide on autoimmune phenomena in NZB mice.
    Lemmel E; Hurd ER; Ziff M
    Clin Exp Immunol; 1971 Feb; 8(2):355-62. PubMed ID: 4102260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical analysis of the use of azathioprine in clinical medicine.
    Ten Berge RJ; Schellekens PT
    Neth J Med; 1983; 26(6):164-71. PubMed ID: 6350911
    [No Abstract]   [Full Text] [Related]  

  • 3. Auto-immunity and systemic lupus erythematosus.
    Whaley K
    Med Lab Technol; 1972 Apr; 29(2):133-42. PubMed ID: 4116076
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic lupus erythematosus.
    Koffler D
    Sci Am; 1980 Jul; 243(1):40-9. PubMed ID: 6450445
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunosuppressive treatment of rheumatic diseases. Experimental bases of a rational concept of therapeutic approach (author's transl)].
    Lemmel EM; Botzenhardt U
    Arzneimittelforschung; 1976; 26(7):1281-95. PubMed ID: 1087561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapy in systemic lupus erythematosus].
    Deicher H
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):215-7. PubMed ID: 4538326
    [No Abstract]   [Full Text] [Related]  

  • 7. Selected problems in immunosuppressive therapy.
    Rondio H
    Mater Med Pol; 1974; 6(1):34-40. PubMed ID: 4613962
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression by cyclophosphamide in NZB X NZW mice with lupus nephritis.
    Casey TP
    Blood; 1968 Sep; 32(3):436-44. PubMed ID: 4175452
    [No Abstract]   [Full Text] [Related]  

  • 9. [The immunosuppressive agents. 3. The immunosuppressive agents in hematology].
    Meshaka G; Jacquillat C; Sultan Y
    Presse Med (1893); 1967 Jul; 75(32):1653-5. PubMed ID: 6067478
    [No Abstract]   [Full Text] [Related]  

  • 10. [Recommendations for immunosuppressive therapy in systemic lupus erythematosus].
    Deicher H
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):249-51. PubMed ID: 4115641
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapy of autoimmune nephropathy with steroids and cytostatics. A follow-up study of 80 patients and of 16 years.
    Petrányi G; Leövey A; Szegedi G; Kakuk G; Bobory J
    Acta Med Acad Sci Hung; 1971; 28(1):97-106. PubMed ID: 5133501
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
    Fox DA; McCune WJ
    Concepts Immunopathol; 1989; 7():20-78. PubMed ID: 2676180
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of renal injury in systemic lupus erythematosus.
    Koffler D; Kunkel HG
    Am J Med; 1968 Aug; 45(2):165-9. PubMed ID: 4174390
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations].
    Fuks A; Carballal G; Manni JA
    Medicina (B Aires); 1979; 39(3):289-97. PubMed ID: 514050
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of systemic lupus erythematosus (SLE) with immunosuppressive drugs 1: An analysis of immunologic data.
    Cruchaud A; Pometta D; Rousso C
    Helv Med Acta; 1967 Dec; 34(1):5-22. PubMed ID: 4173836
    [No Abstract]   [Full Text] [Related]  

  • 16. Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.
    Zulman J; Michalski J; McCombs C; Greenspan J; Talal N
    Clin Exp Immunol; 1978 Feb; 31(2):321-7. PubMed ID: 306328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Depression of the primary immunity reaction by 6-mercaptopurine and cyclophosphamide in various animal species. II. Different effect of 6-mercaptopurine and cyclophosphamide on the antibody formation of rabbits, guinea pigs, rats, and mice].
    Finger H
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(2):105-20. PubMed ID: 5584703
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of dazmegrel, piroxicam and cyclophosphamide on the NZB/W model of SLE.
    Archer RL; Cunningham AC; Moore PF; Potter JA; Bliven ML; Otterness IG
    Agents Actions; 1989 Jun; 27(3-4):369-74. PubMed ID: 2801326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutics. XI. Immunosuppressive drugs.
    Ashton H; Beveridge GW; Stevenson CJ
    Br J Dermatol; 1970 Aug; 83(2):326-30. PubMed ID: 4916789
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible NZB syndrome in man.
    Oken MM; Griffiths RW; Williams RC; Reimann BE
    Arch Intern Med; 1973 Aug; 132(2):237-40. PubMed ID: 4124195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.